United Kingdom · Question · Written question
HL HL11669
Drugs: Manufacturing Industries
Introduced
5 November 2025
Last action
18 November 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
18 November 2025
Summary
To ask His Majesty's Government what assessment they have made of which medicines should be prioritised for reshoring or nearshoring of manufacture, and what estimate they have made of the investment required to achieve this.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 November 2025
Written question
To ask His Majesty's Government what assessment they have made of which medicines should be prioritised for reshoring or nearshoring of manufacture, and what estimate they have made of the investment required to achieve this.
Source: Lords
18 November 2025
Answer
The Government is committed to strengthening the United Kingdom’s domestic medicines manufacturing capabilities, now and in the future, using a range of levers to support the sector more broadly.The key lever, the Life Sciences Innovative Manufacturing Fu...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-11-05/HL11669
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1849217
- uk · wq-1849217 · source updated 18 November 2025